TORONTO, ONTARIO--(Marketwired - March 26, 2014) - NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) is pleased to announce its 2013 annual results.
Revenue from transaction fees for the year ended December 31, 2013 was $4,910,517 representing an increase of 12%, cost of sales decreased by 11% and gross profit increased by 18% over the prior year.